Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Gly16Arg Polymorphism in ADRB2 Gene on Asthma Control in Children Receiving Long Acting Beta Agonists

NCT01108627 is registered in ClinicalTrials.gov with Nemours Children's Clinic as lead sponsor.

NCT NCT01108627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01108627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Gly16Arg Polymorphism in ADRB2 Gene on Asthma Control in Children Receiving Long Acting Beta Agonists
Lead sponsor
Nemours Children's Clinic
Phase
Phase 4
Overall status
Withdrawn
Start date
October 31, 2010
Completion date
December 31, 2011
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

safety of long acting beta agnoists